‘Bedrock of Australia Street’: Why this Newtown spot remains a firm favourite

It’s been 11 years since the arrival of this fancy delicatessen and bistro. Good Food visits to see if it still holds its own ...

No Soil Needed: The Stunning Flower You Can Grow In A Bowl Of Water On Your Porch

When it comes to selecting flowers for your sunny porch, you may want to think out of the box ... or rather, the soil. Here's ...
STAT

How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward

Matthew Herper covers medical innovation — both its promise and its perils. Everything changed with a white envelope. On Dec. 20, 2018, Jacob Van Naarden, the chief operating officer of a biotech ...
CNBC

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Eli Lilly will pay up to $7.8 billion to acquire Centessa Pharmaceuticals. Centessa is developing orexin agonists to treat narcolepsy and excessive drowsiness. The deal is the latest from Lilly, which ...
Forbes

FDA Approves Eli Lilly’s Weight Loss Pill—Second Weight GLP-1 Drug In Pill Form

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The Food and Drug Administration has approved Foundayo, Eli Lilly’s new GLP-1 pill to treat ...
FierceBiotech

Lilly further embraces Insilico’s AI tech, inking R&D collab worth up to $2.75B

After an initial AI software licensing deal between Eli Lilly and Insilico Medicine three years ago, the companies are deepening their ties once again with a drug discovery and development ...
CNBC

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

Hong Kong-listed Insilico Medicine has reached a deal with U.S. pharma giant Eli Lilly for AI-discovered drugs. The two companies have worked together since 2023. Insilico's CEO, Alex Zhavoronkov, ...
Bloomberg L.P.

Lilly’s Obesity Pill Gets US Approval in Challenge to Novo

Eli Lilly & Co.’s weight-loss pill won US approval, ratcheting up pressure on Novo Nordisk A/S, which launched an obesity pill earlier this year. Lilly’s once-daily pill, called Foundayo, was approved ...
Yahoo Finance

Lilly’s Obesity Pill Gets US Approval in Challenge to Novo

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Bloomberg L.P.

Lilly to Buy Sleep Drug Maker Centessa in $7.8 Billion Deal

Eli Lilly & Co. agreed to buy sleep drug maker Centessa Pharmaceuticals Plc in a deal worth up to $7.8 billion, a sign the weight-loss medication giant is looking to bulk up its treatment pipeline for ...
Wall Street Journal

Eli Lilly, InSilico Strike AI Drug Discovery Deal

Eli Lilly LLY-0.91%decrease; red down pointing triangle signed a drug discovery deal with InSilico that the Hong Kong-listed company says could be valued at as much as $2.75 billion, as global ...
The Motley Fool

Is Eli Lilly Stock a Buy After a Brand New Approval?

Eli Lilly received approval for a weight-loss pill. This new product should help strengthen its market position. There are several other reasons to invest in Eli Lilly. On April 1, Eli Lilly announced ...